Results 91 to 100 of about 22,313 (170)

Mechanistic Insights into Fosfomycin Resistance: Examination of the FosX Class of Fosfomycin Resistance Proteins

open access: yes, 2005
The objective of this research was to examine the FosX class of metalloenzymes utilized by pathogenic microorganisms for resistance to the antibiotic fosfomycin.
Beihoffer, Lauren Ashley
core  

Activity of Fosfomycin- and Daptomycin-Containing Bone Cement on Selected Bacterial Species Being Associated with Orthopedic Infections [PDF]

open access: yes, 2017
The purpose of this study was to determine activity of fosfomycin/gentamicin and daptomycin/gentamicin-containing PMMA bone-cement against Staphylococcus aureus (MRSA, MSSA), Staphylococcus epidermidis, Enterococcus faecium (VRE), and E. coli (ESBL; only
Kevin Hofpeter   +13 more
core   +2 more sources

Fosfomycin killing of giant cell-minus mutants.

open access: yes, 2019
The survival of bacteria in liquid protective medium following exposure to fosfomycin (192 μg/ml) was assayed. Wild type cells exposed to fosfomycin in liquid medium were smaller and less prone to lysis than on agar medium.
Joe Gasper (261641)   +5 more
core   +1 more source

In vitro efficacy of fosfomycin against clinical strains [PDF]

open access: yesJournal of Microbiology and Infectious Diseases, 2014
Objective: Fosfomycin is an alternative drug for treatment of uncomplicated urinary tract infections. This study aimed to investigate in vitro activity of fosfomycin against ethicillinresistant Staphylococcus aureus (MRSA), methicillinresistant ...
Adil Karadağ   +4 more
doaj  

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

open access: yes, 2020
Fosfomycin is a new agent to Canada approved for the treatment of acute uncomplicated cystitis (AUC) in adult women infected with susceptible isolates of E. coli and Enterococcus faecalis.
Andrew J Walkty   +2 more
core  

Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study

open access: yesAntibiotics
Background: Fosfomycin is used as a combination partner for the treatment of severe non-urinary tract infections. Individualized dosing of fosfomycin based on therapeutic drug monitoring (TDM) has the potential to reduce drug-related adverse events (AEs).
Kathrin Marx   +9 more
doaj   +1 more source

Fosfomycin in antimicrobial stewardship programs.

open access: yes, 2019
Due to the increase in antimicrobial resistance, strategies such as antimicrobial stewardship programs (ASP) have been developed to improve the clinical results, decrease the adverse effects and the development of resistances and ensure cost-effective ...
Ramos Martínez, A   +2 more
core  

Optimising use of fosfomycin against multidrug-resistant Pseudomonas aeruginosa

open access: yes, 2016
Rising resistance to most antibiotics coupled with a marked decline in antibiotic discovery has led to a recent increase in the use of fosfomycin for treatment of systemic infections due to multidrug-resistant (MDR) bacteria, including MDR Pseudomonas ...
Walsh, Clare Cathleen
core  

Fosfomycin susceptibility in infected cells.

open access: yes, 2018
Intracellular survival of wild-type P14 (WT) and isogenic ΔfosX mutant demonstrating the lack of effect of FosX on L. monocytogenes susceptibility during infection.
Lei Han (150108)   +6 more
core   +1 more source

Evaluating The Role of Fosfomycin in Treating MDR Urinary Pathogens: A Tertiary Care Hospital Perspective

open access: yesJournal of Pure and Applied Microbiology
Urinary tract infections (UTIs) are most common infections encountered in both community and hospital settings and are frequently treated with antibiotics.
Susmitha Simgamsetty   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy